Search

Search Results

• The influence of thiotriazoline on the indicators of nitric oxide under the condition of experimental contact dermatitis and experimental pneumonia

  M. M. Regeda-Furdychko

  35-40

  2020-02-04
• Particularities of hemodynamics and oxygen status in infants and preschool-age children with complicated community-acquired pneumonias

  Yuliia Viacheslavivna Horodkova, Mykhailo Yurievich Kurochkin

  227-239

  2020-05-29
• How to diagnose, treat and prevent from hospital-acquired and ventilator-associated pneumonia?

  Rafał Babiak, Karolina Bajak, Paulina Czuchryta, Anastazja Domańska, Agnieszka Gawęda, Agata Grabek, Julia Rutkowska, Żaneta Rzęsa-Tokarczyk, Klaudia Skorek, Agnieszka Urbańczyk

  61-74

  2023-06-05
• Evaluation of the influence of thiotriazoline on the cytokine status disturbances in the blood serum under the condition of experimental contact dermatitis and experimental pneumonia

  M. M. Regeda-Furdychko

  25-30

  2020-01-14
• Characteristic of individual indicators of phagocytic activity of leukocytes under conditions of formation of experimental contact dermatitis and experimental pneumonia and the effect of the drug thiotriazoline

  M. M. Regeda-Furdychko

  322-327

  2019-10-30
• Pathogenetic substantiation of thiotriazoline use on the basis of disorders of proteolysis processes and protease inhibitors under conditions of contact dermatitis and experimental pneumonia

  M. M. Regeda-Furdychko

  584-589

  2019-06-28
• Role of dynamic thoracoscopy in treatment of pleural complications of bacterial destruction of the lungs in children

  A. Losev, D Samofalov

  209-218

  2014-04-30
• Pneumonia as an impediment to treat patients in the early period after stroke

  Katarzyna Małodobry, Małgorzata Juda, Dorota Ozga

  723-734

  2018-08-19
• Assessment of the clinical course of community acquired pneumonia in young patients, taking into account the CMV-persistence and its severity

  K. D. Chichirelo-Konstantynovych

  31-41

  2020-01-16
• Lefamulin - a recently developed antibiotic for treatment of community-acquired bacterial pneumonia (CABP)

  Leila Abod, Natalia Ilnicka, Daria Matyja, Maria Sadlik, Patrycja Zuziak

  186-196

  2023-09-07
• The level of endogenic intoxication in the dynamics of development of experimental contact dermatitis and experimental pneumonia and their correction by thiotriazoline

  M. M. Regeda-Furdychko

  287-292

  2019-11-29
• The effect of thiotriazoline on impaired immune system in experimental pneumonia and contact dermatitis

  M. M. Regeda-Furdychko

  320-324

  2019-12-28
• Influence of tiotriazoline on the infringed cytokin profile indicators in the six period of formation of pulmonary patients with haulage of experimental pneumonia

  L. O. Furdychko

  897-902

  2017-04-25
• Violation of specific indicators pigment and lipid metabolism in experimental pneumonia in an immobilization stress and correction of corvitin

  N. M. Ferenc

  709-713

  2015-09-30
• The functional status of the prooksidant and antioxidant systems in the liver in the dynamics of formation of experimental pneumonia

  Nataliya M. Ferents

  180-184

  2015-10-24
• Features changes phagocytic activity of leukocytes in development of peptic ulcer under pneumonia

  L. O. Furdychko

  723-730

  2017-05-31
• Characteristics of Influenza A/H1N1 complications: ARDS, pneumonia, acute kidney failure, sepsis - review

  Kacper Lee, Jakub Skrzypek, Jagoda Niewiadomska, Aleksandra Stępień, Alicja Paluch, Borys Bondos , Aleksandra Niekra, Łukasz Fussek, Robert Kochan, Ewelina Wieczorek

  58075

  2025-04-07
• The corvitini role in the corrections disturbances of proteinase inhibitors system in blood under conditions of the development of experimental bacterial keratitis on the background of experimental bronchial asthma and pneumonia

  B. B. Kravets

  141-145

  2015-10-22
• Status of individual indicators of cytokin profile in the early period of development of viral disease duration on the blood of experimental pneumonia

  L. O. Furdychko, R. Z. Ohonovsky

  629-634

  2017-06-30
• Revolutionizing Pneumonia Assessment: Modern Diagnostics and Traditional Scales

  Marcelina Sikora, Marta Zarzycka, Ines Plewniok, Monika Maj-Dziedzic, Jeremiasz Dubiel, Anna Brzozowska, Adrian Maj, Greta Śmietana, Martyna Warno, Wiktor Kozik

  122-136

  2024-01-29
• Venovenous extracorporeal membrane oxygenation (VV ECMO) in community-acquired pneumonia caused by Klebsiella pneumoniae. What went wrong?

  Krystian Adrian Ślusarz, Paulina Kurdyś, Patrycja Łanowy, Miłosz Bichalski, Bartosz Bijak, Ewa Trejnowska

  738-746

  2019-08-11
• Diagnosis and Treatment of Sepsis in a Fourteen-year-old Patient: A case study of pulmonary inflammatory discharge without typical features of respiratory tract infection

  Bartłomiej Żaczek, Jakub Kozłowski, Alicja Kamińska, Wojciech Kupczak, Kinga Bujak, Aleksandra Kocjan, Ismael Alsoubie, Natalie Papachristoforou, Wojciech Kaźmierski, Mateusz Ziomek, Paulina Lis, Marta Czubaj-Kowal

  56959

  2025-01-30
• Changes in individual indicators of protein metabolism in experimental pnevmonia in a imobilizatsiynoho stress and correction corvitin

  Nataliya M. Ferents

  141-148

  2015-02-27
• Indices of Inborn Immunity (TLR2, Interleukins 1 β and 10) in Cases of Pneumonia among Newborn Infants

  O. Yablon, N. Zaichko, I. Reminna

  519-530

  2017-03-23
• Liver dysfunction in children with community-acquired pneumonia: the role of infectious and inflammatory markers

  Veronika Dudnyk, Valentyna Pasik

  169-181

  2021-11-29
• Hiccup as an uncommon symptom of pneumonia

  Paulina Terlecka, Anna Grzywa-Celińska, Justyna Emeryk-Maksymiuk, Katarzyna Szmygin-Milanowska, Janusz Milanowski

  111-117

  2017-12-12
• The effect of corvitin on the impaired indicators of the proteinase-inhibitory system in the kidneys under the conditions of the development of experimental pneumonia and adrenaline damage to the myocardium

  M. Regeda, N. Shklyarskyi

  56502

  2024-10-30
• Role of immune and metabolic processes in pathogenesis of the development of chronic periodontitis and pneumonia and correction of their impairment with quercetin

  O. O. Chuhai, M. S. Reheda, S. M. Reheda

  786-798

  2017-01-27
• Meaning of indices of nitric oxide system for early period of peptic ulcer disease formation in the presence of pneumonia

  L. O. Furdychko, Ya. O. Pohoretska

  269-273

  2018-01-31
• The effect of corvitin on the indicators of the nitric oxide system in the kidneys under the conditions of the development of experimental pneumonia and adrenaline damage to the myocardium

  M. Regeda, N. Shklyarskyi

  56501

  2024-09-24
• The role of disorders of immune processes in the pathogenesis of the formation of periodontitis on the background of experimental pneumonia and their correction tetrazolium

  S. M. Regeda

  350-358

  2017-01-24
• Influence of indicators for thiotriazolin phagocytic activity of leukocytes in the blood in the later period of development of stomach ulcers against pneumonia

  L. O. Furdychko

  1310-1315

  2017-07-31
• The impact of quantitative and semi-quantitative culture of respiratory tract secretions on clinical decisions in a patient with suspected pneumonia – case study

  Kamila Kasprzycka, Marcin Węglarz, Martyna Lewkowicz, Gracjana Ratuszny

  76-85

  2023-08-24
• Severe Legionella pneumophila pneumonia treated with extracorporeal membrane oxygenation (ECMO): A case report

  Paulina Kurdyś, Krystian Ślusarz, Ewa Trejnowska

  681-689

  2019-09-22
• THE VIOLATION OF LIPID PEROXIDATION PRODUCTS AND ACTIVITY OF ANTIOXIDANT SYSTEM ENZYMES IN THE LUNGS IN THE CONDITIONS OF EXPERIMENTAL ASTMA AND PNEUMONIA ON A BACKGROUND CORRECTION OF CORVITINI

  B. Kravets

  84-88

  2015-12-23